Pertussis vaccination in pregnancy, dTaP/IPV (Boosterix® or Repevax®): PGD template

PGD template to support the national pertussis vaccination for pregnant women immunisation programme.


Diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (dTaP/IPV) for pregnant women: patient group direction (PGD) template

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email Please tell us what format you need. It will help us if you say what assistive technology you use.


This patient group direction (PGD) template supports the administration of low dose diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (dTaP/IPV) by currently registered nurses or midwives. This applies to women from 16 weeks of pregnancy in accordance with the pertussis vaccination for pregnant women national immunisation programme for active immunisation of the pregnant woman and to provide passive immunity in the neonate against pertussis. It is valid from 1 April 2017 to 31 March 2019.

This template requires further authorisation by an appropriate authorising person, relating to the class of person by whom product is to be supplied, in accordance with the Human Medicines Regulations 2012 (HMR). This may be a clinical governance or patient safety lead, who has designated responsibility for signing PGDs on behalf of the authorising body. The PGD is not legal or valid without signed authorisation in accordance with HMR 2012 schedule 16 part 2.

Adoption and governance of the use of this PGD is the responsibility of the authorising organisation and provider.

Provider organisations, health professionals and immunisation practitioners should check they are working to the current PGD versions and only work to documents authorised in accordance with HMR 2012 schedule 16 part 2.

These PGDs should be used with reference to the Green Book, and Summary of Product Characteristics for the vaccine.

Published 7 January 2016
Last updated 6 April 2017 + show all updates
  1. Updated vaccine eligibility changed from 20 weeks to 16 weeks of pregnancy.
  2. Updated pertussis pregnancy PGD: vaccine eligibility changed from 28 to 20 weeks of pregnancy.
  3. First published.